Zhejiang Tianyu Pharmaceutical Co., Ltd.

SZSE:300702.SZ

20.8 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q1
Revenue 569.891682.895662.311518.57569.175777.214582.284610.46724.036749.898605.175572.702608.21758.923583.272672.126763.207568.792527.766604.618479.774498.438463.302357.104347.634298.917305.309273.961322.427286.587266.396240.29313.444
Cost of Revenue 393.369445.896419.106307.038335.038476.039449.34470.008561.158498.63408.814374.893387.184441.309346.129278.212353.596273.071204.284251.359212.82256.283234.239197.573245.54198.916208.232164.683186.983179.173167.458147.099193.36
Gross Profit 176.521237243.205211.532234.137301.175132.945140.452162.878251.267196.361197.809221.026317.614237.143393.914409.61295.72323.482353.259266.953242.155229.063159.531102.094100.00197.077109.278135.444107.41498.93893.191120.084
Gross Profit Ratio 0.310.3470.3670.4080.4110.3880.2280.230.2250.3350.3240.3450.3630.4190.4070.5860.5370.520.6130.5840.5560.4860.4940.4470.2940.3350.3180.3990.420.3750.3710.3880.383
Reseach & Development Expenses 59.99250.05862.68658.81969.8252.49764.57960.60755.11950.79864.46152.15263.8146.97860.34352.99441.52824.19934.09730.60726.30122.90624.85619.12554.27116.68678.869.31330.247058.73010.925
General & Administrative Expenses -38.06476.815-115.005167.8-42.98985.652-147.981218.519-43.7599.724-184.006245.174-20.42999.11-159.918100.711-9.31267.849-94.578.094-18.39264.182-70.20161.417-27.69661.626-102.46656.835-23.98455.584-96.35351.81147.096
Selling & Marketing Expenses 29.49924.44336.57919.89528.09713.21413.73214.3719.7439.584.5549.5738.8529.224-11.11112.72318.0813.65315.3910.5428.7448.86518.3976.8485.6336.5978.3455.5157.7185.4696.7716.9746.252
SG&A 87.592101.274-78.426187.696-14.89198.867-134.249232.891-34.007109.304-179.452254.747-11.577108.333-171.029113.4348.76881.502-79.1188.636-9.64873.048-51.80368.264-22.06368.222-94.12262.35-16.26761.053-89.58258.78553.348
Other Expenses -18.243-12.5755.107-0.225-2.655-1.058-4.217-1.617-2.612-0.223-16.848-2.097-2.026-0.7010.924-4.9750.512-1.3899.803-0.62912.271-0.886-19.998-1.137-1.832-0.212-7.4172.5873.917-0.2793.4770.8771.171
Operating Expenses 165.827163.907219.895138.27161.94153.614182.68168.504138.414157.521180.172175.945184.189156.818153.117169.18154.298103.258158.868121.629107.55290.579118.14290.28983.47769.90473.43966.34974.30462.30574.9761.10655.856
Operating Income 10.69473.093-30.042-0.576-25.803127.168-166.855-49.28614.85799.45-1.65434.30550.711156.718100.378231.777248.009195.581166.524225.827143.481152.4898.5550.10420.71426.368-3.40934.84749.89838.55221.45328.65253.175
Operating Income Ratio 0.0190.107-0.045-0.001-0.0450.164-0.287-0.0810.0210.133-0.0030.060.0830.2070.1720.3450.3250.3440.3160.3740.2990.3060.2130.140.060.088-0.0110.1270.1550.1350.0810.1190.17
Total Other Income Expenses Net -0.836-12.3675.107-0.225-2.655-1.058-4.217-1.617-2.612-0.223-16.848-2.097-2.026-0.7010.924-4.975-1.429-1.389-2.196-0.629-0.499-0.886-3.27-1.137-1.832-0.212-6.5512.5183.12-0.2791.0670.5941.067
Income Before Tax 9.85860.726-24.935-0.801-28.457126.11-171.072-50.90312.24599.227-18.50232.20848.685156.018101.302226.802246.58194.192164.329225.198142.982151.59495.2848.96718.88226.156-9.9637.36453.01838.27322.5229.24654.242
Income Before Tax Ratio 0.0170.089-0.038-0.002-0.050.162-0.294-0.0830.0170.132-0.0310.0560.080.2060.1740.3370.3230.3410.3110.3720.2980.3040.2060.1370.0540.088-0.0330.1360.1640.1340.0850.1220.173
Income Tax Expense -4.02119.41316.502-1.4843.66825.872-13.3555.2812.01714.505-17.1356.7851.52522.55712.16430.16531.78627.722.93635.17317.07823.4310.4810.681-1.3285.804-4.036.6188.8017.1251.0852.759.45
Net Income 12.69840.517-41.4360.683-32.126100.238-157.718-56.18410.22884.721-1.36825.42347.16133.46189.138196.637214.794166.492141.393190.025125.904128.16484.838.28720.2120.352-5.9330.74744.21731.14821.43526.49644.792
Net Income Ratio 0.0220.059-0.0630.001-0.0560.129-0.271-0.0920.0140.113-0.0020.0440.0780.1760.1530.2930.2810.2930.2680.3140.2620.2570.1830.1070.0580.068-0.0190.1120.1370.1090.080.110.143
EPS 0.0370.12-0.120.002-0.0930.29-0.46-0.160.0290.24-0.0040.070.140.690.280.610.660.520.430.590.40.390.260.120.0610.061-0.0190.130.180.130.0890.110.19
EPS Diluted 0.0370.12-0.120.002-0.0930.29-0.46-0.160.0290.24-0.0040.070.140.680.280.60.660.510.430.580.390.380.260.120.0610.061-0.0190.130.180.130.0890.110.19
EBITDA 92.82480.4798.46856.28883.97129.678-89.313-26.75954.815107.1576.40331.65150.484189.50684.981209.72254.667194.657169.815241.073172.261141.3683.47577.74534.29528.5113.51841.29762.22745.16343.12731.06467.364
EBITDA Ratio 0.1630.1180.0130.1090.1480.167-0.153-0.0440.0760.1430.0110.0550.0830.250.1460.3120.3340.3420.3220.3990.3590.2840.180.2180.0990.0950.0440.1510.1930.1580.1620.1290.215